Monitoring and treatment of intestinal allograft rejection in humans.
Abu-Elmagd
K M
KM
Department of Surgery, University of Pittsburgh Medical Center, Pennsylvania.
Tzakis
A
A
Todo
S
S
Reyes
J
J
Fung
J
J
Nakamura
K
K
Wright
H
H
Furukawa
H
H
Demetris
J
J
Van Thiel
D H
DH
D000208:Acute Disease; D000328:Adult; D000527:Alprostadil / Q000627:therapeutic use; D017209:Apoptosis; D002648:Child; D002908:Chronic Disease; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D006801:Humans; D007421:Intestine, Small / Q000473:pathology / Q000637:transplantation*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008991:Monitoring, Physiologic; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D000527:Alprostadil; D016559:Tacrolimus; D008775:Methylprednisolone